U.S. FDA Advisers Vote Unanimously In Favor Of XBB-Tailored Covid-19 Vaccines For 2023-24 Vaccination Campaign
Portfolio Pulse from Benzinga Newsdesk
U.S. FDA advisers have voted unanimously in favor of XBB-tailored Covid-19 vaccines for the 2023-24 vaccination campaign. Companies like AZN, BNTX, JNJ, MRNA, NVAX, and PFE may be involved.
June 15, 2023 | 8:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AstraZeneca may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that AZN may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
BioNTech may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that BNTX may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Johnson & Johnson may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that JNJ may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Moderna may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that MRNA may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Novavax may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that NVAX may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Pfizer may be involved in the production of XBB-tailored Covid-19 vaccines for the 2023-24 campaign.
The article mentions that PFE may be involved in the production of the XBB-tailored Covid-19 vaccines. This could lead to increased revenues and a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50